Annual report pursuant to Section 13 and 15(d)

Summary of Stock Options Activity (Details)

v3.23.1
Summary of Stock Options Activity (Details) - USD ($)
12 Months Ended
Dec. 09, 2021
Dec. 31, 2022
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]      
Number of Shares, Beginning Balance   4,176,737  
Weighted Average Exercise Price, Beginning Balance   $ 2.59  
Weighted Average Grant Date Fair Value, Beginning   $ 2.59  
Weighted Average Remaining Contractual Term (Years), Ending   7 months 20 days 1 year 3 months 14 days
Aggregate Intrinsic Value, Beginning Balance   $ 14,493,284  
Number of Shares, Granted   300,000  
Weighted Average Exercise Price, Granted   $ 3.41  
Weighted Average Grant Date Fair Value, Granted   $ 3.41  
Weighted Average Remaining Contractual Term (Years), Granted   5 years 9 months 18 days  
Number of Shares, Exercised 11,576  
Weighted Average Exercise Price, Exercised    
Weighted Average Grant Date Fair Value, Exercised    
Number of Shares, Forfeited    
Weighted Average Exercise Price, Forfeited    
Weighted Average Grant Date Fair Value, Forfeited    
Number of Shares, Canceled/Expired    
Weighted Average Exercise Price, Canceled/Expired    
Weighted Average Grant Date Fair Value, Canceled/Expired    
Number of Shares, Ending Balance   4,476,737 4,176,737
Weighted Average Exercise Price, Ending Balance $ 2.59 $ 2.64 $ 2.59
Weighted Average Grant Date Fair Value, Ending   $ 2.64 $ 2.59
Number of Shares, Exercisable   4,376,737  
Weighted Average Exercise Price, Exercisable   $ 2.61  
Weighted Average Grant Date Fair Value, Exercisable   $ 2.61  
Weighted Average Remaining Contractual Term (Years), Exercisable   6 months 7 days